- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
The timing and extent of androgen deprivation therapy for prostate cancer: Weighing the clinical evidence - Abstract
September 27, 2011
New hormonal therapies for castration-resistant prostate cancer - Abstract
September 27, 2011
Androgens and prostate cancer bone metastases: Effects on both the seed and the soil - Abstract
September 27, 2011
Patient preoperative expectations of urinary, bowel, hormonal and sexual functioning do not match actual outcomes 1 year after radical prostatectomy - Abstract
September 27, 2011
Editor's Commentary - Patient expectations on sexual function following prostate cancer treatment
September 27, 2011
Complications and postoperative events after cryosurgery for prostate cancer - Abstract
September 26, 2011
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer - Abstract
September 26, 2011
Second-line therapy for castrate-resistant prostate cancer: A literature review - Abstract
September 26, 2011
Racial variation in the cost-effectiveness of chemotherapy for prostate cancer - Abstract
September 26, 2011
Calcium intake and prostate cancer among African Americans: Effect modification by vitamin D receptor calcium absorption genotype - Abstract
September 26, 2011
Proton therapy for prostate cancer - Abstract
September 26, 2011
Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases - Abstract
September 23, 2011
Tumor focality is not associated with biochemical outcome after radical prostatectomy - Abstract
September 23, 2011
Stage of disease progression moderates the association between social support and depression in prostate cancer survivors - Abstract
September 23, 2011
Time trends in prostate cancer surgery: Data from an Internet-based multicentre database - Abstract
September 23, 2011